Stock market anomaly | Zai Ding Pharmaceuticals (09688.HK) rose more than 4%, with the innovative schizophrenia drug Kailie Le listed and the cervical cancer new drug approved for marketing in China.

According to the Securities Times APP, RenDing Pharmaceuticals (09688.HK) rose by over 4%, as of the time of publication, it had risen by 4.06% to 13.07 Hong Kong dollars, with a trading volume of 156 million Hong Kong dollars.